Related Experiment Video

Updated: Jul 11, 2026

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific

Martin Sauvageau1, Michelle Miller, Sébastien Lemieux

  • 1Molecular Genetics of Stem Cells Laboratory, Institute for Research in Immunology and Cancer, University of Montreal, and Division of Hematology, Maisonneuve-Rosemont Hospital, Quebec, Canada.

Blood
|October 2, 2007
PubMed

Insights

Proviral insertional mutagenesis can now identify more cancer genes. This study reveals deregulated genes near retroviral insertion sites, aiding lymphoid leukemia research.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Proviral insertional mutagenesis is valuable for discovering cancer genes.
  • Limitations in gene expression analysis have hindered gene discovery.
  • A new model using Eed Polycomb group gene mutant mice was developed.

Purpose of the Study:

  • To characterize a new model of insertional mutagenesis-induced lymphoid tumors.
  • To quantitatively determine gene expression levels near retroviral common insertion sites (CISs).
  • To identify cancer-associated genes deregulated by proviral insertions.

Main Methods:

  • Characterization of lymphoid tumors from Eed mutant mice.
  • Identification of 20 retroviral common insertion sites (CISs).
  • High-throughput quantitative reverse transcription-polymerase chain reaction (Q-RT-PCR) to measure gene expression levels within 100 kb of CISs.

Main Results:

  • An average of 13 CIS-associated genes were deregulated per tumor.
  • Half of deregulated genes were leukemia subtype-specific; others were coordinately deregulated.
  • Genes distant from CISs were as frequently deregulated as proximal genes, with multiple genes affected per integration.

Conclusions:

  • The study identified a conserved group of deregulated genes in similar lymphoid leukemia subtypes.
  • This approach advances the identification of common molecular determinants in lymphoid leukemias.
  • The findings suggest a more comprehensive understanding of insertional mutagenesis in cancer gene discovery.

More Related Videos

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library07:28

Identification of Functionally-Relevant Lentivirus Integration Sites in an Insertional Mutagenesis Cell Library

Published on: January 10, 2025

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...